Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Thoracic Cancer|October 3, 2018
Adjuvant radiotherapy, chemotherapy or surgery alone for high-risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trialXufeng Guo, Wentao Fang, Zhigang Li, et al.European Radiology|September 22, 2023
Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancerXiaoyu Han, Mingliang Wang, Yuting Zheng, et al.Translational Lung Cancer Research|September 21, 2020
Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS)Dingpei Han, Yuqin Cao, Han Wu, et al.Eclinicalmedicine|October 23, 2025
AI-derived longitudinal and multi-dimensional CT classifier for non-small cell lung cancer to optimize neoadjuvant chemoimmunotherapy decision: a multicentre retrospective studyGuanchao Ye, Zhitao Wei, Chu Han, et al.Lung Cancer (Amsterdam, Netherlands)|September 13, 2025
Chinese expert consensus on perioperative management of patients with resectable anaplastic lymphoma kinase-fusion non-small cell lung cancerHai-Yan Tu, Chun Chen, Chang Chen, et al.JAMA Surgery|March 17, 2021
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical TrialHao Wang, Han Tang, Yong Fang, et al.Nature Medicine|July 2, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialJianjun Qin, Liyan Xue, Anlin Hao, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 5, 2021
[Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer]Jun Ni, Miao Huang, Li Zhang, et al.Journal of Cancer Research and Therapeutics|August 29, 2024
Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition)Baodong Liu, Xin Ye, Weijun Fan, et al.Pageof 8